SB 450 Oregon Senate · 2023 Regular Session

Relating to opioids.

Summary

Exempts from labeling requirements drug intended to reverse opioid overdose when drug is dispensed by physician or physician assistant ] health care provider .

Bill status signed all 5 stages cleared

Introduction

Jan 2023

Committee Review

May 2023

Senate Passage

Jun 2023

House Passage

Jun 2023

Signed into Law

Jul 2023

Introduced Jan 9, 2023 Signed Jul 13, 2023

Floor votes · Senate Mar 28, 2023 · House May 25, 2023

How they voted

28–0

Passed · 1 other

Total votes 29

Mar 28, 2023

D Democratic17

16 Yea 1

94% Yea

I Independent1

1 Yea

100% Yea

R Republican11

11 Yea

100% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jul 13, 2023

Signed into law

Governor signed.

upper

Jun 20, 2023

Lower · Passed

Speaker signed.

lower

Jun 20, 2023

Upper · Passed

President signed.

upper

Jun 15, 2023

Introduced

Vote explanation(s) filed by Smith DB.

upper

Jun 15, 2023

Upper · Passed

Senate concurred in House amendments and repassed bill.

upper

May 25, 2023

Lower · Passed

Read third time under Consent Calendar. Passed.

lower

May 16, 2023

Lower · Passed

Recommendation: Do pass with amendments and be printed A-Engrossed.

lower

Mar 28, 2023

Committee

Referred to Behavioral Health and Health Care.

lower

Mar 28, 2023

Introduced

First reading. Referred to Speaker's desk.

lower

Mar 28, 2023

Upper · Passed

Third reading. Carried by Bonham. Passed.

upper

Mar 23, 2023

Upper · Passed

Recommendation: Do pass.

upper

Jan 14, 2023

Committee

Referred to Health Care.

upper

Jan 9, 2023

Introduced

Introduction and first reading. Referred to President's desk.

upper

1 primary · 1 co-sponsor